DEARBORN PARTNERS LLC – Eli Lilly and Company Transaction History
DEARBORN PARTNERS LLC portfolio value:
$1.52M
portfolio value
DEARBORN PARTNERS LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +2.79% | 128 shares | 37K | $323.35 | 4.70K |
Q2 2022 | share | Increase | +2.23% | 100 shares | 202K | $324.23 | 4.58K |
Q1 2022 | share | Decrease | -0.31% | -14 shares | 42K | $286.37 | 4.48K |
Q4 2021 | share | 0.00% | 0 shares | 203K | $277.25 | 4.49K | |
Q3 2021 | share | Increase | +0.13% | 6 shares | 8K | $230.3 | 4.49K |
Q2 2021 | share | 0.00% | 0 shares | 192K | $228.04 | 4.48K | |
Q1 2021 | share | Increase | +3.10% | 135 shares | 103K | $184.81 | 4.48K |
Q4 2020 | share | Increase | +13.71% | 525 shares | 168K | $166.32 | 4.35K |
Q3 2020 | share | Decrease | -8.36% | -349 shares | -119K | $145.05 | 3.82K |
Q2 2020 | share | Increase | +0.58% | 24 shares | 110K | $160.1 | 4.17K |
Q1 2020 | share | Increase | +19.13% | 667 shares | 118K | $134.64 | 4.15K |
Q4 2019 | share | 0.00% | 0 shares | 68K | $126.91 | 3.48K | |
Q3 2019 | share | Decrease | -0.77% | -27 shares | 1K | $107.36 | 3.48K |
Q2 2019 | share | Decrease | -7.11% | -269 shares | -102K | $105.74 | 3.51K |
Q1 2019 | share | 0.00% | 0 shares | 53K | $123.17 | 3.78K | |
Q4 2018 | share | Decrease | -0.16% | -6 shares | 32K | $109.26 | 3.78K |
Q3 2018 | share | Increase | +30.62% | 888 shares | 159K | $100.8 | 3.78K |
Q2 2018 | share | 0.00% | 0 shares | 23K | $79.72 | 2.9K | |
Q1 2018 | share | Decrease | -11.31% | -370 shares | -52K | $71.78 | 2.9K |
Q4 2017 | share | 0.00% | 0 shares | -4K | $77.79 | 3.27K | |
Q3 2017 | share | 0.00% | 0 shares | 11K | $78.29 | 3.27K | |
Q2 2017 | share | 0.00% | 0 shares | -6K | $74.85 | 3.27K | |
Q1 2017 | share | Increase | 0.00% | 3.27K shares | 275K | $76 | 3.27K |